OSAM
VIR icon

O'Shaughnessy Asset Management’s Vir Biotechnology VIR Stock Holding History

O'Shaughnessy Asset Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,012
Closed -$44K – 2450
2021
Q3 		$44K Sell
1,012
-712
-41% -$30.8K ﹤0.01% 1694
2021
Q2 		$81K Sell
1,724
-5
-0.3% -$227 ﹤0.01% 1391
2021
Q1 		$89K Buy
+1,729
New +$93.2K ﹤0.01% 1245

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
APF
Alaska Permanent Fund Juneau, Alaska $1.51B AUM 22.23% 1-Year Est. Return

O'Shaughnessy Asset Management's VIR Position: Q4 2021 in Review

O'Shaughnessy Asset Management sold out of Vir Biotechnology (VIR) in Q4 2021, closing a stake of 1,012 shares — an estimated $44K sold.

O'Shaughnessy Asset Management first reported a position in VIR in Q1 2021 and held it in 3 quarters. The position peaked at $89K in Q1 2021. 210 funds tracked by Wall St. Rank hold VIR as of Q4 2021.

  • O'Shaughnessy Asset Management reported no remaining Vir Biotechnology position as of Q4 2021 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 1,012 Vir Biotechnology shares in Q4 2021, an estimated $44K.
  • O'Shaughnessy Asset Management first reported a position in Vir Biotechnology in Q1 2021 and held it in 3 quarters.
  • O'Shaughnessy Asset Management's Vir Biotechnology position peaked at $89K in Q1 2021.
  • 210 funds tracked by Wall St. Rank held Vir Biotechnology as of Q4 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.